Issue: February 2013
February 01, 2013
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
PROTECT AF
Issue: February 2013
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Trial compared percutaneous left atrial appendage (LAA) closure with the Watchman filter device vs. warfarin for preventing stroke in AF patients.